Hepatocellular Carcinoma (MSK, Clin Cancer Res 2018)

Summary

Hepatocellular Carcinoma (MSK, Clin Cancer Res 2018) is a study catalogued by cBioPortal DataHub under the cancer-type code hcc. EvidenceHelix groups it with liver, bile duct and gallbladder studies.

Study description

MSK-IMPACT sequencing of 127 Hepatocellular Carcinoma tumor samples with matched normals.

Text as published in the source's study metadata.

Citation & PubMed

Harding et al. Clin Cancer Res 2018

Linked PubMed records: PMID 30373752

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

hcc_mskimpact_2018

Short name

HCC (MSK 2018)

Source cancer-type code

hcc

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Harding et al. Clin Cancer Res 2018

• PubMed record 30373752 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)

  Targeted sequencing of 1,370 hepatobiliary cancer samples (with 1366 matched normals) via MSK-IMPACT. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-…

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (MSK, JCO Precis Oncol 2023)

  Targeted sequencing of 51 hepatocellular carcinoma patients and their matched normal samples via MSK-IMPACT.

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Liver Hepatocellular Adenoma and Carcinomas (MSK, PLOS One 2018)

  Targeted sequencing of tumor/normal pairs of 9 LIAD and 10 HCC patients via MSK-IMPACT platform.

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (CLCA, Nature 2024)

  The Chinese Liver Cancer Atlas (CLCA) project. Deep whole-genome sequencing of 494 hepatocellular carcinomas and their matched normals. Data from CLC Atlas (http://lifeome.net:8080/clca/#/).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (MERiC/Basel, Nat Commun. 2022)

  Whole-exome sequencing of 122 Hepatocellular carcinomas and their matched normals. Dataset was generated in 2021 by MERiC and Charlotte Ng (hg19 original; Basel/Bern research pipeline).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Hepatocellular Carcinomas (INSERM, Nat Genet 2015)

  Whole-exome sequencing of 243 liver tumors and matched normals.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Liver Hepatocellular Carcinoma (AMC, Hepatology 2014)

  Whole exome sequencing of 231 hepatocellular carcinomas and matched normal tissue pairs.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Liver Hepatocellular Carcinoma (RIKEN, Nat Genet 2012)

  Whole-genome sequencing of 27 hepatocellular carcinoma tumor/norma pairs from RIKEN.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.